ArticleLipids in health and disease2026
Associations of metabolic indicators and inflammation-related indices with adverse cardiovascular events in US adults: NHANES 1999-2018.
Article in Lipids in health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of anxiety, depressive symptoms, and inflammatory indices with cardiometabolic multimorbidity.Brain, behavior, & immunity - health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProcesses in cardiovascular disease (CVD) are associated with metabolic perturbations and inflammation. The mediating role of inflammation in connecting metabolic factors to adverse cardiovascular outcomes and the joint effects of both factors on CVD and mortality are poorly understood.
methodsA total of 18,741 individuals from the National Health and Nutrition Examination Survey 1999–2018 were included in this study. Multivariate survey-weighted logistic regression (for CVD prevalence) and Cox proportional hazards models (for all-cause and CVD mortality) were used to investigate associations among metabolic factors, inflammation-related variables, and adverse cardiovascular outcomes. Mediation analyses were conducted to explore how inflammation may contribute to the relationship between metabolic factors and adverse cardiovascular outcomes. Joint factor models for both metabolic and inflammatory risk factors were developed for comprehensive evaluation.
resultsWith each unit rise in the triglyceride–glucose (TyG) index and Dietary Inflammatory Index (DII), the prevalence of CVD and risks of all-cause and CVD mortality escalated by 22% vs. 6% (odds ratio [OR] = 1.22, 95% confidence interval [CI; 1.06, 1.41] vs. 1.06 [1.02, 1.11]), 20% vs. 12% (hazard ratio [HR] = 1.20, 95% CI [1.09, 1.32] vs. 1.12 [1.09, 1.15], and 29% vs. 12% (HR = 1.29, 95% CI [1.01, 1.64] vs. 1.12 [1.05, 1.18]), respectively. Mediation analysis indicated that the DII accounted for 3.58% (95% CI 3.50%, 3.66%) to 17.05% (95% CI 7.77%, 85.09%) of the association of the TyG and atherogenic index of plasma with the prevalence of CVD and risks of all-cause and CVD mortality. Joint effect analysis according to tertiles (T) revealed that compared with the TyG-T1 + DII-T1 group, the TyG-T3 + DII-T3 group had greater CVD prevalence (OR = 1.45, 95% CI [1.02, 2.06]) and elevated risks of all-cause and CVD mortality (HR = 1.80 95% CI [1.47, 2.21]); 1.75 95% CI [1.14, 2.67]).
conclusionsThe study findings revealed that metabolic disturbances and the inflammatory burden have important roles in increasing the prevalence of CVD and risks of all-cause and CVD mortality. Low-cost laboratory and dietary indicators can complement existing assessment, enabling scalable early risk stratification and prioritized primary care intervention to reduce premature CVD deaths across secondary and tertiary prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.